Top Oncology Solution Companies
Flatiron Health: Combating Cancer With Data Analytics

Top 10 Oncology Solution Companies - 2019

Cancer treatment has been one of the most challenging endeavors for tech firms; it serves as an avenue to reap the rewards of technological advancements for the betterment of patients. However, vendors are in a continuous quest to mitigate the challenges revolving around delivering superior oncology solutions by leveraging latest technologies such as data analytics, artificial intelligence (AI), and Internet of Things (IoT). Various firms are focused on merging patients’ data from different healthcare systems and analyzing it for making informed decisions while diagnosing cancer. Thus, interoperability between electronic health records (EHRs) is paramount for simplifying healthcare services to patients. Health record information is further empowering doctors to supervise patients health condition in real-time to facilitate patient-centric care. Besides, tumor data from several EHRs’ have improved early detection and treatment of cancer before it spreads and afflicts humans.

Although combining data from various sources have immensely assisted doctors in providing the best treatment, effective aggregation of information from a multitude of EHRs is still one of the significant challenges. Consequently, health tech firms are developing application program interfaces (APIs) to integrate these health care systems, enabling doctors to obtain complete picture of tumor severity while diagnosing patients. Such interoperability is also allowing caregivers to monitor post-treatment conditions of their patients and suggest medications accordingly. With patients’ health information at doctors’ fingertips, healthcare providers are able to track the diagnosis through all phases of care and offer the highest level of service without any information gaps. In addition, these datasets are also driving research and development initiatives for devising new drugs to optimize the overall delivery of care by utilizing machine learning (ML) and natural language processing (NLP) models.

As every tumor is different and develops in its own way, the use of data for rendering personalized treatment is assisting doctors in improving the standard of care. Today, researchers can not only look at the genetic code of cancer cells but also compare them with DNA of metastases that develops. The heterogeneous nature of cancer makes its treatment incredibly complex; because, on a molecular level, no two cancers are the same. However, use of data for diagnostics is streamlining the caregivers’ process in providing each patient with a bespoke drug that targets his or her specific cancer cells, thereby, limiting the risk of severe side effects. Data analytics has already become a crucial weapon to fight diseases in the digital age and is further being utilized for increasing collaboration between caregivers and patients, improving communication through the course of diagnosis. Likewise, big data will continue to advance and accelerate the pace of cancer treatment by discovering effective ways in diagnosing patients.

This edition presents to you, “Top 10 Oncology Solution Providers - 2019,” featuring companies who are radically transforming the field of oncology space. Over the past few months, a distinguished panel of CEOs, CIOs, VCs and the editorial team of Healthcare Tech Outlook have reviewed companies in the oncology sector and have shortlisted the forerunners who are meeting the challenges of the industry head-on.

We present to you, “Top 10 Oncology Solution Providers - 2019.”

    Top Oncology Solution Companies

  • ARCHES is a health technology company whose mission is to arm cancer patients with education and information at the precise moments when fear and anxiety are most likely to disrupt their journey. Arches’ HIPAA compliant software platform, Keystone, bolsters communication between healthcare providers and oncology patients by integrating directly with any healthcare system's technology or EMR platform. Using real-time data and machine learning technology, Arches enables organizations to simplify processes, optimize outcomes, increase adherence and loyalty, and make oncology patients the center of every interaction

  • Merit Medical is committed to reducing the burden cancer places on women and their families through unparalleled cancer treatment technology—SAVI SCOUT and SAVI Brachy. Cianna Medical, recently acquired by Merit Medical, developed the SCOUT Radar Localization System. This system is the first solution to use highly sophisticated radar technology in human tissue and enables advanced wire-free localization for any patient undergoing breast conservation surgery. Merit is continuing Cianna Medical’s mission to reduce the burden cancer places on women and their families

  • Electronic Registry Systems, Inc. (ERS) is focused exclusively on the field of cancer registry management. ERS leads cancer registry innovation and provides cancer centers with rich data and insights to help steer the best cancer care for every patient. After more than 30 years in the registry management field, ERS continues to stand at the forefront of innovation and leads the industry in technology, education and client-support services. ERS’s true cloud-based cancer registry management solution, CRStar by ERS, provides individual cancer centers, as well as large enterprise health systems, a fully compliant and secure data management solution that meets and exceeds regulatory, accreditation and quality reporting requirements. CRStar by ERS creates a knowledge center of actionable information relied upon by oncology professionals to help guide key resource management, planning and program growth decisions with an emphasis on quality and research

  • Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. The company's innovative platform enables cancer researchers and care providers to learn from the experience of every patient by leveraging big data. Flatiron develops software programs to connect community oncologists, academics, hospitals, life science researchers, and regulators on a shared technology platform. Currently, the firm partners with over 280 community cancer practices, seven major academic research centers and over 15 of the top therapeutic oncology companies

  • Kognitic’s advanced clinical trial intelligence platform, Onclogik, helps in accelerating clinical trial design and approval of new novel cancer drugs. The cloud-based Onclogik platform leverages natural language processing (NLP) and machine learning (ML) algorithms to collect data from multiple sources such as, published journals, and other online articles. By Leveraging Onclogik, clients can optimize their clinical trial design and gain approval from regulatory authorities in the shortest amount of time. Alongside, they can have a better understanding of emerging market trends and innovative therapies that are being introduced so that they can align their drug development operations accordingly

  • Mevion Medical Systems is a leading provider of proton therapy systems for use in precision radiation oncology. Mevion Medical Systems was founded to bring forth a new approach to proton therapy with superior performance while being drastically more affordable than traditional systems. Built upon the world’s only gantry-mounted proton accelerator, Mevion’s revised version of the traditional proton therapy system—the MEVION S250™Series—is a compact single-room, a high-powered solution that delivers exceptional beam quality, stability, and uptime—making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. This novel cancer-fighting tool empowers more cancer centers to provide this remarkable cancer-fighting capability to their radiation oncologist teams

  • Wamberg Genomic Advisors (WGA) is a California-based oncology solutions provider that makes cutting-edge genomics and oncology products accessible to business employers, insurance policyholders, and patients in a quick and cost-effective manner. Leverages three decades of industry expertise, the company develops innovative benefits and financial strategies for employers of all sizes and insurance companies, and accelerate their access to genomic solutions. That being said, WGA also offers solution and services to bolster the alignment between patients and policyholders to enhance the health, wellness, and longevity of individuals and insurers alike

  • Body Vision

    Body Vision

    Body Vision Medical specializes in augmented real-time imaging, artificial intelligence, and intra-body navigation. The early commercial-stage medical device company offers FDA approved, fully reimbursed LungVision platforms designed to address the clinical need of diagnostics and treatment of lung cancer. Body Vision Medical was founded in 2014 by Dorian Averbuch, who pioneered, built, and commercialized a revolutionary electronic navigation bronchoscopy method at SuperDimension. The LungVision products and tools enable healthcare specialists to reach the nodules in the deep periphery of the lungs accurately, allowing seamless integration with multiple off-the-shelf operational tools and modalities. Body Vision Medical collaborates with physicians, clinical specialists, and engineers from different medical fields, pioneering an excellent standard of care for lung diagnostics

  • Derma Sensor

    Derma Sensor

    The company specializes in packaging best-in-class support, customer education, and a cloud solution that fits the evolving needs of cancer registry. ERS strives to accentuate the clinical expertise of the Cancer Tumor Registrar (CTR) to better serve the needs of the Cancer Center and their patients – beyond the narrow objective of meeting accreditation-reporting needs. This includes supporting cancer research initiatives and clinical trial programs. ERS is focused on leveraging innovation, including NLP to optimize identification of all reportable cancer cases and allow the CTR to focus on broader tasks that leverage their clinical expertise

  • Dilon Diagnostics

    Dilon Diagnostics

    Dilon aims to develop, acquire, and market quality products and services to enhance the quality of life for patients. Dion Technologies is dedicated to delivering intraoperative systems and clinically useful imaging, which is useful for early disease detection and surgical applications. The company’s primary products include Diagnostic Imaging, Surgical Imaging, and Airway Imaging. Dilon Molecular Breast Imaging System is a high-resolution compact camera that has been optimized for Molecular Breast Imaging (MBI) procedure for early diagnosis of breast cancer. The Dilon Navigator® Gamma Probe is a popularly used gamma probe for cancer surgery in the marketplace. The CoPilot VL® is an affordable and innovative video laryngoscope that streamlines intubation and airway management